![]() |
市場調查報告書
商品編碼
2025023
金奈米顆粒市場規模、佔有率、趨勢和預測:按類型、應用、終端用戶產業和地區分類,2026-2034年Gold Nanoparticles Market Size, Share, Trends and Forecast by Type, Application, End-Use Industry, and Region, 2026-2034 |
||||||
2025年全球金奈米顆粒市場規模為63億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以9.27%的複合年成長率成長,到2034年達到144億美元。目前,北美市場佔據主導地位,預計2025年市佔率將超過31.4%。這一優勢歸功於該地區先進的醫療基礎設施、強大的奈米技術企業以及對研發的大量投入。此外,有利的法規環境以及在診斷和藥物傳輸領域不斷擴展的應用也進一步鞏固了北美在金奈米顆粒市場的主導地位。
金奈米粒子在精準醫療領域,尤其是在癌症治療診斷學和光熱治療方面,其日益重要的角色正推動著這一市場的發展。對標靶藥物傳遞系統的需求不斷成長,以及金奈米粒子優異的表面功能化特性,正加速其在生物醫學領域的應用。此外,對奈米技術研究和學術合作的投入不斷增加,也推動了各領域的快速創新。例如,2024年2月,果阿大學的研究人員開發了一種突破性的環保型金奈米粒子合成方法,該方法利用白蟻巢穴中發現的一種本土白蟻菌屬真菌。這項創新工藝使用可食用的真菌生質能代替有毒化學物質,建立了一條清潔環保的生產路線。這項技術可望降低印度對進口的依賴,並建立價值約4.5億美元的全球金奈米粒子本地供應鏈。在電子產業,金奈米粒子也被應用於導電油墨和奈米電路製造領域。環境感測技術和觸媒轉換器受益於金奈米顆粒的穩定性和反應活性,從而進一步拓展了其應用領域。專利申請的不斷增加和國際資金的支持,正在加速金奈米顆粒產品在眾多產業的商業化進程。
在美國,由生物技術新創公司、學術研究機構和聯邦研究經費(尤其是來自美國國立衛生研究院 (NIH) 和國家科學基金會(NSF) 的經費)組成的強大生態系統正在推動金奈米顆粒市場的成長。美國對先進診斷工具和奈米醫學的早期應用,加速了金奈米顆粒在分子成像和生物感測器領域的應用。健全的智慧財產權體系增強了投資者的信心,並促進了商業化進程。此外,美國國防部對用於醫療和檢測用途的奈米材料的興趣也推動了需求的成長。國內半導體和電子產業擴大利用金奈米顆粒製造小型化和高性能元件。這些因素共同作用,使得美國在全球金奈米顆粒市場格局中扮演著舉足輕重的角色。
醫療應用擴展
在全球範圍內,對用於癌症治療、診斷成像和標靶藥物遞送的奈米技術的大量投資正在刺激市場發展。例如,2023年11月發表在《奈米生物技術雜誌》(Journal of Nanobiotechnology)上的一篇綜述介紹了利用奈米技術遞送傳統中藥活性成分的現有數據。該綜述指出,無機奈米載體,例如金奈米顆粒(Au NPs),由於其較大的表面積、尺寸以及可控的表面電荷,正逐漸成為藥物遞送應用的新興選擇。近期報告預測,全球奈米醫藥市場將從2025年的2,659億美元快速成長至2034年的6,321億美元,這反映了市場對奈米級藥物遞送介質和診斷成像劑日益成長的需求,其複合年成長率(CAGR)高達10.1%。此外,2024年1月發表在ScienceDirect上的報導重點評估了採用環境友善方法合成的金奈米顆粒(AuNPs)作為癌症治療中多功能治療診斷劑的潛力。本研究的主要目的是報告利用綠色奈米技術製備金奈米顆粒(AuNPs)的最新突破。此外,這些顆粒具有獨特的光學和化學性質,使其適用於標靶藥物傳遞。這反過來又擴大了對金奈米顆粒的需求。例如,2023年10月,機械工程博士生範漢文與葛曉倩博士和秦振鵬博士合作,開發了一種利用金奈米顆粒將藥物遞送至血腦障壁的方法。此外,研究人員也展示了該方法在治療膠質母細胞瘤(最常見的人類腦腫瘤類型)方面的應用。另外,2023年9月,印度科學研究所(IISc)的研究人員宣布了一種旨在檢測和摧毀癌細胞(特別是形成固態腫瘤的癌細胞)的創新方法。正如發表在《ACS應用奈米材料》雜誌上的一項研究中所詳述的那樣,他們開發了一種由硫化銅和金組成的混合奈米顆粒。這些奈米粒子能夠透過產生熱量殺死癌細胞,並可透過聲波進行檢測。
對先進電子設備的需求日益成長
隨著電子設備小型化趨勢的推進,這些具有優異導電性和穩定性的奈米粒子的應用日益廣泛,成為推動成長要素。例如,2024年1月,浦項科技大學(POSTECH)的研究團隊開發了一種基於溶液的3D列印技術,能夠低成本地製造任意形狀的超材料。研究團隊利用此方法,將金奈米粒子和二氧化矽奈米粒子的蒸發共組裝與3D奈米列印技術結合,製備出自由形狀、自主型狀超分子(RMMs)纖維。此外,這些奈米粒子在光學感測器和薄膜電晶體的製造領域有著廣泛的應用,這提升了金奈米粒子市場的前景。 2024年5月,《國家科學評論》發表的一項研究介紹了表面等離子體的動態可逆光調製。這項研究結合了透過光激發熱電子實現的半導體光電操控技術,從而改變了奈米間隙的電導率和金中的電荷密度。由此,它為奈米光子處理器提供了一個重要的光電開關原型。美國半導體產業協會(SIA)指出,美國半導體供應鏈的投資金額已超過5,400億美元。這一成長帶動了基於奈米顆粒的互連、感測器和超材料等領域的研發。
安全和監管的考慮
鑑於這些顆粒在包括醫療保健和消費品在內的多個行業中有著廣泛的應用,政府機構正致力於實施嚴格的監管。美國國家標準與技術研究院 (NIST) 已為生物醫學研究界發布了奈米顆粒的參考標準。此外,歐洲藥品管理局 (EMA) 和美國食品藥物管理局 (FDA) 等監管機構也積極制定金奈米顆粒安全使用的指南和標準。另外,根據《有毒物質管制法》(TSCA),許多奈米材料被視為「化學品」。因此,美國環保署 (EPA) 已發布法規,要求對現有奈米化學品的暴露情況以及健康和安全資訊進行一次性報告和記錄。此外,在含金奈米顆粒產品的開發和核准過程中所進行的綜合安全評估數量不斷增加,也推動了金奈米顆粒市場的發展。例如,2023年7月,美國食品藥物管理局(FDA)核准了一種利用金奈米顆粒提高成像準確性的新型診斷工具,但該工具需經過嚴格的臨床前和臨床試驗,以確保其有效性和安全性。此外,2024年1月,一項新的歐盟指令訂定,強制要求對消費品中所含奈米材料進行可追溯性和標籤標註,旨在提高透明度和消費者安全。
The global gold nanoparticles market size was valued at USD 6.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 14.4 Billion by 2034, exhibiting a CAGR of 9.27% during 2026-2034. North America currently dominates the market, holding a significant market share of over 31.4% in 2025. This dominance can be attributed to the region's advanced healthcare infrastructure, strong presence of nanotechnology firms, and high investment in research and development. Favorable regulatory frameworks and growing applications in diagnostics and drug delivery further contribute to North America's leading position in gold nanoparticle market share.
The market is being driven by their expanding role in precision medicine, particularly in cancer theranostics and photothermal therapy. Growing demand for targeted drug delivery systems and the superior surface functionalization properties of gold nanoparticles are encouraging their integration in biomedical applications. Additionally, rising investments in nanotechnology-based research and academic collaborations are facilitating rapid innovation across sectors. For instance, in February 2024, researchers at Goa University developed a pioneering eco-friendly method to synthesize gold nanoparticles using indigenous Termitomyces mushrooms found on termite mounds. This innovative process replaces toxic chemicals with edible fungal biomass, creating a clean, green production route. The technique offers India the potential to reduce reliance on imports and build a local gold nanoparticle supply chain valued at approximately USD 450 Million globally. The electronics industry is also adopting gold nanoparticles for conductive inks and nanoscale circuit fabrication. Environmental sensing technologies and catalytic converters benefit from their stability and reactivity, further diversifying usage. Increasing patent activity and supportive international funding are collectively accelerating the commercialization of gold nanoparticle-based products across multiple industries.
In the United States, the gold nanoparticles market growth is propelled by a robust ecosystem of biotech startups, academic research institutions, and federal research funding, particularly from the NIH and NSF. The country's early adoption of advanced diagnostic tools and nanomedicine accelerates the use of gold nanoparticles in molecular imaging and biosensors. The strong intellectual property framework enhances investor confidence, fostering commercialization efforts. Moreover, the U.S. Department of Defense's interest in nanomaterials for medical and detection purposes contributes to demand. Domestic semiconductor and electronics industries increasingly leverage gold nanoparticles for miniaturized and high-performance components. These factors collectively contribute to the United States' prominent role in shaping the global gold nanoparticles market landscape.
Rising Medical Applications
Extensive investments in nanotechnology for cancer therapy, diagnostic imaging, and targeted drug delivery are stimulating the market across the globe. For instance, in November 2023, a review published by researchers in the Journal of Nanobiotechnology showcased existing data on nanotechnology-based delivery of active components of traditional Chinese medicines (TCMs). They described the emergence of inorganic nanocarriers, such as gold nanoparticles (Au NPs), for drug delivery, owing to their large surface area, customizable size, surface charge, etc. A recent report projects the global nanomedicine market will soar from USD 265.9 Billion in 2025 to USD 632.1 Billion by 2034, posting a robust 10.1 % CAGR, reflecting growing demand for nanoscale drug-delivery vehicles and imaging agents. Additionally, an article generated by ScienceDirect in January 2024 highlighted the evaluation of gold nanoparticles (AuNPs) that were synthesized utilizing environmentally friendly methods for their potential as multipurpose theragnostic agents in cancer treatment. The primary focus of this research reported recent breakthroughs in the production of AuNPs by adopting green nanotechnology techniques. Moreover, the unique properties of these particles make them suitable for targeted drug delivery due to their unique optical and chemical properties. This, in turn, is escalating the gold nanoparticles market demand. For instance, in October 2023, mechanical engineering doctoral student Hanwen Fan, as well as research associates Dr. Xiaoqian Ge, and Dr. Zhenpeng Qin, developed a method by utilizing gold nanoparticles designed to deliver medication through the blood-brain barrier. Furthermore, the researchers demonstrated the method for treating glioblastoma, the most common human brain cancer. Apart from it, in September 2023, researchers at the Indian Institute of Science (IISc) introduced an innovative method aimed at detecting and destroying cancer cells, particularly those forming solid tumors. As detailed in a study published in "ACS Applied Nano Materials," they developed hybrid nanoparticles composed of copper sulfide and gold. These nanoparticles have the ability to eliminate cancer cells through heat generation and facilitate their detection via sound waves.
Growing Demand for Advanced Electronics
The increasing trend of miniaturization of electronic devices is elevating the adoption of these particles, on account of their excellent conductivity and stability, which is acting as a significant growth-inducing factor. For instance, in January 2024, a research group at Pohang University of Science and Technology (POSTECH) developed a solution-based 3D printing technique to produce metamaterials affordably in customized shapes. Using this approach, the team fabricated freeform, freestanding raspberry-like metamolecule (RMM) fibers by integrating the evaporative co-assembly of gold and silica nanoparticles with 3D nanoprinting technology. Moreover, these particles find extensive applications in the manufacturing of photo-sensors and thin-film transistors, which is positively creating the gold nanoparticles market outlook. In May 2024, a study in the National Science Review showcased the dynamic and reversible optical modulation of surface plasmons. The research combines the optoelectronic manipulation of semiconductors that can be achieved by optically stimulating the hot electrons, which, in turn, modifies the conductivity of the nanogaps and the charge density in gold. Consequently, it offers a significant optoelectronic switch prototype for use in nanophotonic processors. The Semiconductor Industry Association notes that over USD 540 Billion in U.S. semiconductor-supply-chain investments are now in motion, a surge that is intensifying R&D into nanoparticle-enabled interconnects, sensors, and metamaterials.
Safety and Regulatory Considerations
Government bodies are focusing on implementing stringent regulations, owing to the widespread applications of these particles in several industries, especially in healthcare and consumer products. The National Institute of Standards and Technology (NIST) across the United States issues reference standards for nanoscale particles targeted for the biomedical research community. Additionally, regulatory authorities, such as the European Medicines Agency (EMA) in Europe and the FDA in the United States, are actively working to establish guidelines and standards for the safe use of gold nanoparticles. Additionally, many nanoscale materials are regarded as "chemical substances" under the Toxic Substances Control Act (TSCA). Consequently, the Environmental Protection Agency (EPA) issued a rule requiring one-time reporting and recordkeeping of existing exposure and health and safety information on nanoscale chemical substances. Apart from this, the rising number of comprehensive safety assessments that are conducted during the development and approval process of products containing gold nanoparticles is also elevating the gold nanoparticles market revenue. For instance, in July 2023, the FDA approved a new diagnostic tool utilizing gold nanoparticles for enhanced imaging, contingent upon rigorous preclinical and clinical testing to ensure its efficacy and safety. Furthermore, in January 2024, a new European directive was introduced that mandates traceability and labeling of nanomaterials in consumer products aimed at increasing transparency and consumer safety.
Water soluble stand as the largest type in 2025, holding around 44.6% of the market. The water-soluble segment dominates the gold nanoparticles market due to its superior biocompatibility, stability, and versatility in biomedical applications. Water-soluble gold nanoparticles easily disperse in physiological environments, making them ideal for drug delivery, imaging, and therapeutic interventions. Their ability to be functionalized with various biomolecules enhances targeting efficiency in diagnostics and treatment. Moreover, their low toxicity and ease of synthesis in aqueous media support their widespread use in academic and clinical research. As healthcare and life sciences increasingly rely on nanotechnology for non-invasive procedures, the demand for water-soluble formulations continues to rise, solidifying their dominant position in the gold nanoparticles market.
Imaging leads the market with around 21.1% of market share in 2025. The imaging segment dominates the gold nanoparticles market due to the exceptional optical and electronic properties of gold nanoparticles, which enable highly sensitive and precise imaging techniques. Their strong surface plasmon resonance enhances contrast in imaging modalities such as computed tomography (CT), photoacoustic imaging, and optical coherence tomography. Gold nanoparticles can also be engineered to target specific cells or tissues, improving diagnostic accuracy in oncology and cardiovascular research. Their stability, biocompatibility, and ease of surface modification make them ideal agents for non-invasive and real-time imaging. This broad applicability and performance advantage drive the segment's leading position in the gold nanoparticles market.
Healthcare leads the market with around 49.1% of market share in 2025. The healthcare segment dominates the gold nanoparticles market due to their growing use in diagnostics, targeted drug delivery, and therapeutic applications. Gold nanoparticles offer excellent biocompatibility, tunable surface chemistry, and enhanced permeability, making them ideal for biomedical use. In diagnostics, they are utilized in assays, biosensors, and imaging agents to improve detection sensitivity and speed. In therapeutics, they enable precise drug delivery and photothermal therapies for cancer treatment, minimizing side effects. Continuous advancements in nanomedicine and increased R&D investments by pharmaceutical companies and academic institutions have further accelerated their adoption. These advantages firmly establish healthcare as the leading end-use sector in the gold nanoparticles market.
In 2025, North America accounted for the largest market share of over 31.4%. North America dominates the gold nanoparticles market due to its strong research infrastructure, high healthcare expenditure, and early adoption of advanced nanotechnology across medical and industrial sectors. The region is home to leading biotechnology and pharmaceutical companies actively investing in nanomedicine development. Robust funding from both government agencies and private institutions supports innovation in drug delivery, diagnostics, and imaging technologies. Additionally, regulatory clarity and a well-established intellectual property framework encourage commercialization of gold nanoparticle-based applications. The presence of key market players, strong academic collaborations, and a growing demand for precision medicine further reinforce North America's leading position in the global gold nanoparticles market. For instance, in March 2024, the Wiess School of Natural Sciences at Rice University, United States, introduced the Center for Nanoscale Imaging Sciences to improve the capture, analysis, and interpretation of images at the nanometer scale, contributing to breakthroughs in fields, such as materials science, biology, nanotechnology, and biomedicine.
UNITED STATES GOLD NANOPARTICLES MARKET ANALYSIS
In 2025, the United States held a market share of around 88.70% in North America. The United States gold nanoparticles market is witnessing robust growth due to rising applications in precision medicine and diagnostics. The increasing focus on personalized healthcare and targeted drug delivery systems is propelling the demand for gold nanoparticles, especially in oncological research. This funding is significantly enhancing nanotech research capabilities across academia and industry. Furthermore, expanding government and private investments in nanotechnology-based innovations are supporting the development of novel therapeutic and imaging solutions. As reported, the US federal authorities have provided more than USD1.4 Billion funding for the National Nanotechnology Initiative, which confirms the importance of nanotechnology. Academic collaborations and public-private partnerships are accelerating the integration of gold nanoparticles into next-generation biosensors and theranostics. In addition, the increasing utilization of gold nanostructures in catalysis for environmental remediation and chemical synthesis is widening the application base. The region's advanced research infrastructure and favorable regulatory frameworks are enabling faster commercialization of nanomaterials across pharmaceutical and biomedical sectors. With the rising adoption of food safety testing and advanced material coatings, the market continues to diversify.
EUROPE GOLD NANOPARTICLES MARKET ANALYSIS
The Europe gold nanoparticles market is expanding steadily, driven by increasing emphasis on sustainable nanomaterials in industrial and energy-related applications. Rising interest in green chemistry and cleaner synthesis techniques is contributing to the adoption of gold nanoparticles in catalytic converters, solar cells, and fuel cell technologies. According to the European Union Observatory for Nanomaterials (EUON), around 1.5% of all new cosmetic products notified in Europe contain nanomaterials, reflecting a growing trend toward incorporating nanoscale ingredients in consumer products. Additionally, the push for sustainable electronics and miniaturized components in consumer devices is supporting the use of gold nanoparticles in conductive inks and microelectronic circuits. Academic research in photothermal therapy and nano-optics is also encouraging interdisciplinary utilization. Growth is further reinforced by government funding initiatives focused on environmentally responsible nanotechnology. The integration of gold nanoparticles into bioimaging and biosensing devices for public health applications, including virus detection, adds to the region's innovation landscape.
ASIA PACIFIC GOLD NANOPARTICLES MARKET ANALYSIS
In the Asia Pacific region, the gold nanoparticles market is growing rapidly due to increasing investments in advanced healthcare infrastructure and expanding R&D capabilities. The region's booming electronics manufacturing industry is utilizing gold nanoparticles in flexible electronics and chip-level sensors. According to Invest India, the country's semiconductor sector, valued at USD 23.2 Billion, is projected to grow at a 17.1% CAGR to reach USD 80.3 Billion by 2028, an expansion that is expected to further stimulate demand for nanoscale materials such as gold nanoparticles. In addition, the rising demand for functional cosmetics and dermatological products is driving the use of gold nanomaterials in skincare formulations due to their anti-inflammatory and penetration-enhancing properties. Educational institutions and emerging research hubs contribute significantly to nanoparticle-based product innovation across multiple sectors. With a growing focus on agricultural nanotechnology, gold nanoparticles are being explored for precision farming and pathogen detection in crops.
LATIN AMERICA GOLD NANOPARTICLES MARKET ANALYSIS
The Latin American gold nanoparticles market is gaining momentum, driven by increasing exploration of nanotechnology in environmental monitoring and water purification systems. Research initiatives focused on developing cost-effective sensing platforms for pollutants are fostering demand for gold-based nanostructures. In line with this, upcoming water and sewage auctions in Brazil, scheduled for 2025, could unlock an estimated USD 13 Billion in new investments across 13 states, according to ABCON and BNDES, which boosts nanotech-based water treatment applications. Additionally, there is a rising interest in nano-enabled antimicrobial coatings for public infrastructure and packaging solutions. Academic institutions are actively exploring nanobiotechnology for applications in agriculture and food safety. Growing awareness of nanomaterial benefits in small-scale diagnostics and chemical detection is also encouraging regional uptake.
MIDDLE EAST AND AFRICA GOLD NANOPARTICLES MARKET ANALYSIS
The gold nanoparticles market in the Middle East and Africa is gradually expanding, supported by increasing investments in advanced medical diagnostics and sensor technologies. The integration of nanomaterials into point-of-care testing and portable biosensors is particularly gaining traction. According to IMARC Group, the diagnostic testing market in Saudi Arabia reached USD 1.83 Billion in 2024 and is projected to grow at a CAGR of 4.30% to reach USD 2.79 Billion by 2033, which is expected to further support the integration of gold nanoparticles into diagnostic solutions. There is also a growing emphasis on utilizing gold nanoparticles in photothermal-based treatments and advanced wound care systems. Nanotechnology's growing interest in desalination and clean water initiatives is accelerating the development of gold nanoparticle applications, with technology incubators and academic-led pilot projects accelerating the process.
The competitive landscape of the gold nanoparticles market is characterized by rapid innovation, strategic collaborations, and increasing R&D investments aimed at enhancing product performance and expanding application areas. Market participants are focusing on developing highly functional, biocompatible nanoparticles for use in diagnostics, targeted drug delivery, and imaging. Companies are also investing in scalable and cost-effective synthesis techniques to meet the rising demand across medical and electronics sectors. Regulatory compliance, technological differentiation, and customization capabilities are key competitive factors. The industry also sees frequent academic-industrial partnerships to accelerate innovation. For instance, in July 2025, Merck acquired UK-based Verona Pharma for approximately $10 Billion, enhancing its respiratory treatment portfolio. The move comes as Merck prepares for the upcoming patent expiration of its blockbuster cancer drug, aiming to diversify and strengthen its pipeline. With ongoing advancements and increasing demand for precision healthcare solutions, the gold nanoparticles market forecast projects sustained growth and intensifying competition among global and regional manufacturers over the coming years.